The aim of this study was to compare the correlation of immunohistologically measured Ki 67 protein expression with the Oncotype Dx RS in patients with lymph node-negative ER/progesterone receptor (PR)-positive, HER-2-negative breast cancers. Here, PGR is linked to breast cancer.